The Myasthenia Gravis Foundation of America aims to establish connections, enhance lives, improve care, and ultimately find a cure for Myasthenia Gravis (MG). It supports groundbreaking research and clinical trials worldwide to discover new treatments and ways to live better with MG.
The High Impact Pilot Project Award by the Myasthenia Gravis Foundation of America (MGFA) seeks proposals for clinical research and scientific pilot studies that are innovative and focused. These should either aim at improving patient outcomes through enhanced treatment paradigms or lead to further research supported by federal, pharmaceutical, or private foundations. The research should align with MGFA’s agenda which prioritizes biomarkers, mechanisms of disease, therapeutic strategies, improving patient outcomes, and pediatric treatment strategies. MGFA is open to funding high-quality research outside these areas as well. Funded projects can receive up to $110,000 over two years, with a maximum of $10,000 for indirect costs.